Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Retained Earnings (2016 - 2026)

Trafalgar International (GCAN) posted Retained Earnings of -$5.0 million for Q1 2026, down 0.67% on a QoQ basis from -$5.0 million in Q4 2025, and down 2.5% year-over-year from -$5.2 million in Q1 2025.

Analysis

Trafalgar International (GCAN) Retained Earnings (2016 - 2026) Analysis & Trends

Trafalgar International has reported Retained Earnings for 11 years, with the latest figure at -$5.0 million in Q1 2026.

  • On a quarterly basis, Retained Earnings fell 2.5% year-over-year to -$5.0 million in Q1 2026; TTM through Mar 2026 was -$5.0 million, a 2.5% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 7.12% from the prior year.
  • Retained Earnings was -$5.0 million for Q1 2026 at Trafalgar International, down from -$5.0 million in the prior quarter.
  • The five-year high for Retained Earnings was -$4.1 million in Q1 2022, with the low at -$5.3 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$4.6 million, with a median of -$4.5 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Retained Earnings decreased 18.91% in 2022, then slipped 2.5% in 2026.
  • Over 5 years, Retained Earnings stood at -$4.3 million in 2022, then decreased by 4.39% to -$4.5 million in 2023, then slipped by 4.0% to -$4.7 million in 2024, then declined by 7.12% to -$5.0 million in 2025, then decreased by 0.67% to -$5.0 million in 2026.
  • The last three Retained Earnings figures came in at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 171.67 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -17.33 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 40.86 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 112.09 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -4.00 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 1.10 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 9.16 Bn
10 Trafalgar International 217,335.05 217,335.05 - -5.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.03 Mn
Dec 31, 2025 -4.99 Mn
Sep 30, 2025 -5.33 Mn
Jun 30, 2025 -5.29 Mn
Mar 31, 2025 -4.90 Mn
Dec 31, 2024 -4.66 Mn
Sep 30, 2024 -4.62 Mn
Jun 30, 2024 -4.57 Mn
Mar 31, 2024 -4.53 Mn
Dec 31, 2023 -4.48 Mn
Sep 30, 2023 -4.43 Mn
Jun 30, 2023 -4.38 Mn
Mar 31, 2023 -4.34 Mn
Dec 31, 2022 -4.29 Mn
Sep 30, 2022 -4.25 Mn
Jun 30, 2022 -4.14 Mn
Mar 31, 2022 -4.08 Mn
Dec 31, 2021 -3.93 Mn
Sep 30, 2021 -3.74 Mn
Jun 30, 2021 -3.48 Mn